Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Wouda

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Annals of the Rheumatic Diseases|September 1, 1985
Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease?P M Houtman, C G Kallenberg, A A Wouda, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1989
The effect of six months intensive physical training on the circulation in the legs of patients with intermittend claudicationM P Andriessen, G J Barendsen, A A Wouda, et al.
VASA. Supplementum|January 1, 1987
A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenonJ van der Meer, A A Wouda, C G Kallenberg, et al.
Clinical and Experimental Immunology|January 1, 1979
Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenonJ van der Maulen, A A Wouda, E Mandema, et al.
Annals of the Rheumatic Diseases|August 1, 1988
Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblottingC G Kallenberg, A A Wouda, M H Hoet, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular diseaseE van der Veur, B S ten Berge, A A Wouda, et al.
VASA. Supplementum|January 1, 1987
Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effectsC G Kallenberg, A A Wouda, J J Kuitert, et al.
The Journal of Rheumatology|April 1, 1987
Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effectsC G Kallenberg, A A Wouda, J J Kuitert, et al.
VASA. Supplementum|January 1, 1992
Rheological properties of blood in Raynaud's phenomenonG Wichers, A J Smit, J van der Meer, et al.
Seminars in Arthritis and Rheumatism|August 1, 1994
Serial nailfold capillary microscopy in primary Raynaud's phenomenon and sclerodermaE J ter Borg, G Piersma-Wichers, A J Smit, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Annals of the Rheumatic Diseases|September 1, 1985
Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease?P M Houtman, C G Kallenberg, A A Wouda, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1989
The effect of six months intensive physical training on the circulation in the legs of patients with intermittend claudicationM P Andriessen, G J Barendsen, A A Wouda, et al.
VASA. Supplementum|January 1, 1987
A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenonJ van der Meer, A A Wouda, C G Kallenberg, et al.
Clinical and Experimental Immunology|January 1, 1979
Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenonJ van der Maulen, A A Wouda, E Mandema, et al.
Annals of the Rheumatic Diseases|August 1, 1988
Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblottingC G Kallenberg, A A Wouda, M H Hoet, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular diseaseE van der Veur, B S ten Berge, A A Wouda, et al.
VASA. Supplementum|January 1, 1987
Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effectsC G Kallenberg, A A Wouda, J J Kuitert, et al.
The Journal of Rheumatology|April 1, 1987
Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effectsC G Kallenberg, A A Wouda, J J Kuitert, et al.
VASA. Supplementum|January 1, 1992
Rheological properties of blood in Raynaud's phenomenonG Wichers, A J Smit, J van der Meer, et al.
Seminars in Arthritis and Rheumatism|August 1, 1994
Serial nailfold capillary microscopy in primary Raynaud's phenomenon and sclerodermaE J ter Borg, G Piersma-Wichers, A J Smit, et al.
Pageof 4